iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Reaches New 1-Year High – Still a Buy?

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) shares reached a new 52-week high during trading on Wednesday . The stock traded as high as $87.12 and last traded at $87.0440, with a volume of 52901 shares traded. The stock had previously closed at $85.85.

iShares U.S. Pharmaceuticals ETF Price Performance

The firm has a market capitalization of $984.23 million, a PE ratio of 17.75 and a beta of 0.54. The business has a 50-day simple moving average of $84.38 and a 200-day simple moving average of $75.80.

Institutional Trading of iShares U.S. Pharmaceuticals ETF

A number of institutional investors have recently bought and sold shares of the stock. Harbor Asset Planning Inc. purchased a new position in iShares U.S. Pharmaceuticals ETF during the second quarter worth $27,000. Mather Group LLC. bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 3rd quarter worth about $38,000. Ameriflex Group Inc. lifted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 100.0% in the 3rd quarter. Ameriflex Group Inc. now owns 582 shares of the company’s stock worth $42,000 after acquiring an additional 291 shares during the last quarter. National Bank of Canada FI boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 42.7% during the 3rd quarter. National Bank of Canada FI now owns 585 shares of the company’s stock worth $42,000 after purchasing an additional 175 shares during the period. Finally, CX Institutional boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 2,665.5% during the 3rd quarter. CX Institutional now owns 802 shares of the company’s stock worth $58,000 after purchasing an additional 773 shares during the period.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.